🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareSemaglutide and gallbladder disease risk — my results so far Page 9

Semaglutide and gallbladder disease risk — my results so far

lisa_labSD Wed, Jun 4, 2025 at 10:48 PM 44 replies 2,339 viewsPage 9 of 9
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Mar 20, 2026 at 8:13 PM#41
stefan_berlin said:
Say what you would expect to see if you were wrong, before you look.

Bookmarking. The distinction being drawn above is the one nobody else makes. Taking it to my next appointment.

47 20RunnerRach, TrialNerd_Beth, HPLC_Greg and 44 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Apr 2, 2026 at 12:11 PM#42

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Apr 2, 2026 at 5:11 PM
48 21CryptoCarl, MariaRD, AussieAnna and 45 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 15, 2026 at 4:04 AM#43

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Tagging this one for the weekly digest.

Last edited: Apr 15, 2026 at 6:04 AM
49 22DoseLogDan, SleepFixSam, PurityPaulOR and 46 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
Apr 27, 2026 at 7:48 PM#44
sophie_paris said:
The useful move here is to separate what is established from what is widely repeated.

Coming at sophie_paris’s question from a different direction. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: Apr 27, 2026 at 10:48 PM
50 23wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 47 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
May 10, 2026 at 11:25 AM#45

Adding the numbers, since they settle part of this. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

Last edited: May 10, 2026 at 5:25 PM
1 24RickReta_CO
Reply Quote Save Share Report
1789

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register